


































Preterm	 births	 and	 respiratory	 distress	 syndrome	 (RDS)	 are	 associated	with	 pulmonary	 vascular	 disease	
and	altered	myocardial	 function.	We	serially	assessed	up	to	one	year	of	age	the	effects	of	RDS	on	global	
and	 regional	 myocardial	 function	 of	 preterm	 infants,	 compared	 to	 preterm	 and	 term	 controls	 using	
conventional	echocardiography	parameters,	tissue	Doppler	velocities	and	deformation	analysis.		
Methods	and	results:	
120	 infants	 (30	 preterm	 (PT)	 with	 RDS,	 30	 PT	 controls	 without	 RDS,	 and	 60	 term	 controls)	 underwent	
conventional	and	tissue	Doppler	echocardiography	within	72	hours	of	birth,	at	corrected	term	age	for	the	
preterm	 infants,	at	one	month	corrected,	and	at	one	year	corrected	age.	At	birth,	compared	 to	preterm	
and	 term	 controls,	 the	 PT-RDS	 group	 had	 decreased	 right	 ventricular	 (RV)	 long-axis	 function,	 systolic	
velocity,	peak	systolic	strain,	shorter	pulmonary	arterial	acceleration	time	(PAAT)	and	lower	ratio	of	PAAT	
to	 RV	 ejection	 time	 (PAAT:RVET).	 Preterm	 infants	 had	 left	 ventricular	 (LV)	 diastolic	 dysfunction	 at	 birth	












Extremely	 preterm	 infants	with	 severe	 respiratory	distress	 syndrome	 (RDS)	 have	 evidence	of	 pulmonary	




function	 in	 extremely	 preterm	 infants	 during	 the	 transitional	 period	 and	 serially	 until	 36	 weeks	
postmenstrual	 age.11-13	Myocardial	 function	 of	 extremely	 preterm	 infants	 has	 been	 reported	 to	 improve	
between	serial	 studies	after	birth,	 suggesting	postnatal	maturation.12,13	Myocardial	dysfunction	has	been	
detected	using	TDI	in	neonates	with	pulmonary	hypertension,	asphyxia,	and	bronchopulmonary	dysplasia	
(BPD).14-16	 Less	 is	 known	 about	 the	 effects	 of	 RDS	 on	myocardial	 function	 and	 on	 the	 natural	 history	 of	
cardiac	maturation.		
	
Vitali	 and	 colleagues	 showed	 improved	 right	 ventricular	 (RV)	 systolic	 velocity,	 tricuspid	 annular	 plane	
systolic	excursion	(TAPSE)	and	the	ratio	of	pulmonary	artery	acceleration	time	(PAAT)	to	right	ventricular	
ejection	time	(RVET)	24	hours	after	surfactant	administered	to	premature	infants	with	respiratory	distress	
syndrome.17	 James	 and	 colleagues	 reported	 that	 RV	 systolic	 tissue	 velocity,	 RV	 systolic	 strain	 rate,	 and	
TAPSE	 increased	 between	 day	 1	 and	 day	 2	 of	 life	 in	 extremely	 preterm	 infants.11	 The	 changes	 were	
attributed	to	the	decrease	in	pulmonary	vascular	resistance.	The	same	investigators	also	reported	a	lower	




























post-term,	 and	 at	 one	 year	 corrected	 age.	 Infants	 with	 congenital	 cardiac	 defects	 (other	 than	 patent	
arterial	 duct	 (PDA)	 or	 foramen	 ovale)	 were	 excluded.	 3-beat	 loops	 were	 acquired	 using	 a	 commercial	









velocity	 and	 other	 tissue	 Doppler	 parameters	 were	 recorded,	 according	 to	 consensus	





Early	 diastolic	 velocity	 (Ve’)	 was	 measured	 at	 the	 medial	 and	 lateral	 mitral	 annulus	 and	 averaged.	
Myocardial	 systolic	 velocity	 (Vs),	 early	 diastolic	 velocity	 (Ve)	 and	 velocity	 during	 atrial	 contraction	 (Va)	
were	measured	at	 the	basal	 segments	of	 the	LV	and	RV	 lateral	walls.	When	myocardial	Ve	and	Va	were	




Longitudinal	peak	systolic	 strain	 (Ss)	at	end-systole	was	measured	within	 the	middle	 segments	of	 the	LV	
(Figure	 2)	 and	 RV	 free	 walls,	 using	 a	 region	 of	 interest	 of	 6x3mm	 and	 a	 strain	 length	 or	 computation	
distance	of	6mm	as	we	 found	previously	 that	 that	was	most	 reproducible.10	Systolic	 (SRs),	early	diastolic	
(SRe)	and	 late	diastolic	 (SRa)	 strain	 rates	were	measured	at	 the	same	sites.	Superimposed	event	 timings	










and	 preterm	 groups	 had	 three	 or	 four	 echocardiographic	 assessments	 respectively,	 repeated	measures	





General	 characteristics	 are	 summarized	 in	 Tables	 1	 and	 2;	 the	 PT-RDS	 group	 had	 the	 lowest	 gestation,	










Infants	 in	both	preterm	groups	were	assessed	at	a	 slightly	younger	chronological	 age	compared	 to	 term	
counterparts,	at	“term”	and	at	one	month	and	one	year	of	corrected	age.	Correspondingly,	LVOTd,	and	LV	
















RV	 global	 and	 regional	 systolic	 function,	 as	 indicated	 by	 long-axis	 shortening	 and	 systolic	 velocity,	were	
lower	at	birth	and	at	 corrected	 term	age	 in	 the	PT-RDS	group	 than	 in	both	 control	 groups	 (Table	5).	RV	
systolic	strain	(RV	Ss),	pulmonary	acceleration	time	(PAAT)	and	the	PAAT:RVET	ratio	were	also	lower	in	PT-
RDS	 at	 birth	 (Table	 6).	 By	 one	month	 corrected	 age,	 there	was	 no	 difference	 in	 RV	 strain	 between	 the	
groups	but	PAAT:RVET	 ratio	was	 still	 lower	 in	PT-RDS	group.	RV	early	diastolic	 velocity	was	 lower	 in	 the	
preterm	 groups	 at	 birth	 and	 the	 differences	 resolved	 by	 one	 month	 corrected	 age.	 There	 were	 no	
differences	 in	 RV	 systolic	 and	 diastolic	 strain	 rate	 between	 groups	 at	 birth,	 at	 one	month	 and	 one	 year	
corrected	age.		
	
At	birth,	25	PT-RDS	 infants	 (83%)	had	tricuspid	regurgitation,	compared	with	12	Preterm	Controls	 (40%).	
Pulmonary	regurgitation	(PR)	was	measurable	in	only	8	infants	in	each	group	(27%).	The	velocities	recorded	
were	comparable	(TR	2.0	(0.8)	m/s	 in	PT-RDS,	2.0	(0.8)	m/s	in	Preterm	Controls,	p=0.99;	and	PR	0.6	(0.4)	







than	 in	 term	 controls,	 apart	 from	 LV	 systolic	 and	 diastolic	 strain	 rates	 (Tables	 2-4).	 These	 differences	
disappeared	by	 term	corrected	age	but	stroke	volume	remained	 lower	 in	preterm	groups	whereas	heart	










infants	 with	 RDS,	 and	 compared	 the	 results	 with	 preterm	 and	 term	 control	 infants	 during	 serial	
examinations	recorded	up	to	one	year	of	age.	Our	main	findings	are	that	PT-RDS	infants	had	lower	LV	and	













mechanical	 ventilation	and	20%	 required	 inotropic	 support	with	a	 low-dose	dopamine	 infusion.	Preterm	
myocardium,	which	lacks	sarcoplasmic	reticulum,	relies	mainly	on	the	L-type	calcium	channels	to	trigger	a	
weaker	 muscle	 contraction	 compared	 to	 the	 more	 mature	 infants.26	 Additionally,	 the	 immature	
myocardium	 contains	 a	 higher	 proportion	 of	 non-contractile	 collagen,	 which	 impairs	 relaxation	 and	
ventricular	filling	during	diastole.27	Breatnach	and	colleagues	reported	that	infants	who	received	inotropes	




The	mitral	 E:A	 ratio	was	 lower	 in	 our	 preterm	 groups	 than	 in	 the	 Term	 Controls;	 a	 similar	 pattern	was	
observed	for	fetal	cardiac	function.28,29	When	assessed	at	term,	the	mitral	E:A	ratio	normalized	and	became	
comparable	 to	 term	 infants.	 Two	 other	 groups	 also	 reported	 that	 the	 mitral	 E	 velocity	 continued	 to	
increase	up	to	one	year30,31	implying	that	ventricular	diastolic	function	continues	to	evolve	during	infancy.		
The	E/e’	ratio	is	a	non-invasive	correlate	of	mean	LV	filling	pressure	in	adults	that	to	our	knowledge	has	not	





PT-RDS	 group	where	 the	 differences	 between	 the	 groups	 disappear	 by	 one	month	 corrected	 age.	 Fetal	
studies	have	shown	the	LV	lateral	wall	velocities	increases	from	mid-trimester	to	term29,32	and	Klitsie	and	











28	days	 and	 36	weeks	post-menstrual	 age.12,34	 Levy	 and	 colleagues	 used	 2D	 speckle	 tracking	method	 to	
assess	LV	global	strain	reported	an	initial	increase	in	LV	strain	in	the	first	7	days	of	life	but	thereafter	the	LV	
strain	value	stabilized	until	1	year	corrected	age.18	One	possible	reason	for	this	discrepancy	between	our	
finding	 and	 other	 published	 data	 could	 be	 to	 the	 timing	 of	 the	 assessments.	 Our	 study	 assessed	 these	
infants	within	the	first	72	hours	of	life	and	the	second	follow	assessment	occurred	at	term	corrected	age.	
Another	 possible	 explanation	 could	 be	 underestimation	 of	 the	 LV	 strain	 in	 the	 smallest	 hearts	with	 our	
tissue	Doppler	technique	and	the	difficulty	in	maintaining	a	small	insonation	angle.	However,	the	LV	strain	
of	23±4%	in	the	larger	Term	Controls	at	birth	in	our	study	is	comparable	to	other	reports.6,7,35	The	increases	
in	 LV	 strain	 in	 all	 groups	were	 not	 as	 high	 as	 those	 seen	 in	 the	 RV	 and	 this	 is	 due	 to	 the	 difference	 in	
myocardial	 fiber	 architecture	 between	 LV	 and	 RV.36,37	 Levy	 and	 colleagues	 reported	 infants	 with	 hsPDA	
have	higher	LV	global	strain	but	no	difference	in	LV,	RV,	and	septal	wall	strains	in	infants	with	PDA	that	did	
not	require	treatment	compared	to	those	without	PDA.	18	Strain	rate	was	similar	in	all	groups	at	every	time	






and	the	control	groups	at	birth.	TR	 jet	can	be	difficult	to	be	detected	and	was	only	detected	 in	 less	than	
50%	 of	 infants	 with	 CLD	 and	 pulmonary	 hypertension	 in	 one	 study.5	 Even	 if	 this	 is	 detected,	 TR	 jet	
correlates	 poorly	with	 the	 pulmonary	 arterial	 pressure	measured	 by	 right	 heart	 catheterization	 (RHC).39	
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infants,	 unlike	 tricuspid	 regurgitation	which	was	 detectable	 in	 approximately	 two	 thirds	 of	 the	 preterm	
infants	in	our	study.	
	
Vitali	and	colleagues	assessed	 the	changes	 in	PAAT:RVET,	myocardial	velocities,	 right	and	 left	ventricular	
output	and	TAPSE	at	2	and	24	hours	post	surfactant	administration	 in	a	small	cohort	of	preterm	 infants.	
They	found	an	improvement	in	all	the	parameters	measured	following	surfactant	administration	but	only	
after	 24	 hours	 post	 surfactant	 administration.17	 Our	 PT-RDS	 infants	 had	 significantly	 low	 systolic	
displacement	 of	 the	 tricuspid	 annulus	 (RV	 Ds’)	 and	 RV	 long	 axis	 shortening,	 both	markers	 of	 RV	 global	
systolic	function,	at	birth.	A	similar	reduction	in	regional	function	represented	by	RV	systolic	velocity	and	
strain,	and	 late	diastolic	velocity	were	also	noted	at	birth	 in	the	background	of	raised	pulmonary	arterial	
pressure	 in	 the	PT-RDS	group	compared	to	the	two	control	groups.	These	parameters	 improved	by	term	
corrected	 age	 compared	 to	 preterm	 controls	 implying	 improvement	 of	 RV	 function	 despite	 evidence	 of	
increased	pulmonary	arterial	pressure.	PAAT:RVET	in	the	PT-RDS	group	remained	significantly	lower	at	the	
term	corrected	age	and	persisted	until	one	month	corrected	age.	10	infants	from	PT-RDS	group	fulfilled	the	
BPD	 criteria	 and	 it	 is	 possible	 that	 the	 pulmonary	 pressures	 remained	 elevated.	We	 did	 not	 detect	 any	
residual	RV	systolic	dysfunction	in	our	PT-RDS	group	after	term	corrected	age.	Helfer	and	colleagues	found	
that	infants	who	developed	BPD	had	significantly	lower	RV	free	wall	longitudinal	strain	on	days	14	and	28	
of	 life34.	 Levy	 and	 colleagues	 found	 in	 their	 study,	 infants	 with	 BPD	 and	 pulmonary	 hypertension	 have	
persistent	RV	dysfunction	on	2D	speckle	 tracking	derived	strain	measurements	up	 to	one	year	corrected	






decreased	 RV	 longitudinal	 strain.18	 This	 suggests	 a	 primary	 vascular	 injury	 that	 may	 occur	 in	 some	
extremely	 preterm	 infants,	 independent	 of	 lung	 disease.	We	 reported	 that	 children	 aged	 8-12	who	 had	





The	 preterm	 groups	 showed	 postnatal	 adaptation	 during	 their	 neonatal	 period	 and	 a	 significant	
improvement	 in	their	RV	systolic	 function	(RV	Ds’,	RV	 long	axis	shortening,	RV	 longitudinal	systolic	strain	
and	 RV	 systolic	 strain	 rate)	 and	 RV	 diastolic	 function	 (RV	 Vebl	 and	 RV	 Vabl)	 at	 term	 corrected	 age	
compared	to	the	term	controls	at	birth.	This	progressive	 increase	 in	RV	systolic	 function	could	be	due	to	
the	fall	in	the	pulmonary	vascular	resistance	and	also	suggest	an	increase	in	RV	contractile	function	in	the	
postnatal	period.	It	is	reassuring	to	note	that	both	RV	systolic	and	diastolic	function	of	the	preterm	infants	
continue	develop	 in	 line	with	 the	term	 infants	when	assessed	at	one	month	and	one	year	corrected	age	










PAAT:RVET	 is	 a	 good	 surrogate	 marker	 for	 pulmonary	 artery	 pressure	 or	 compliance.	 LV	 myocardial	
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We	 started	 the	 study	with	 120	 infants	 in	 three	 groups	 but	 follow-up	 rates	 at	 one	month	 and	 one	 year	
represented	64%	and	55%	of	 the	120	 subjects.	We	performed	analysis	 comparing	 infants	who	attended	
follow	ups	at	one	month	or	one	year	corrected	age	and	those	who	dropped	out	and	found	no	difference	in	
baseline	 characteristics	 or	 in	 the	 parameters	 of	 cardiac	 function	 at	 the	 first	 assessment	 (Supplementary	
table	1).	We	are	 satisfied	 that	 those	 followed	up	were	 representative	of	 the	group.	A	 subgroup	analysis	
comparing	BPD	 infants	 and	non-BPD	 infants	within	 the	RDS	group	at	 term	corrected	age	only	 showed	a	





We	used	TDI-derived	 strain	 to	 assess	 LV	 and	RV	 free	wall	 function.	 TDI-derived	 strain	 is	 able	 to	 capture	
images	at	higher	temporal	resolution	compared	to	2D	speckle	tracking	in	the	assessment	of	strain	 in	this	
population	 consisting	 extremely	 preterm	 infants	 who	 have	 high	 heart	 rate.	 We	 decided	 to	 place	 the	

















Preterm	 infants	 with	 RDS	 have	 lower	 left	 and	 right	 ventricular	 systolic	 and	 diastolic	 function	 at	 birth	
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Number	 60	 30	 30	 	
Male	:	Female	(n)	 31:29	 18:12	 21:9	 -	
Gestation	(weeks)	 39.8	(1.2)	 32.7	(1.4)	 28.2	(2.7)	 <0.001§,	§§,	§§§	
Birth	weight	(kg)	 3.4	(0.5)	 1.8	(0.4)	 1.2	(0.4)	 <0.001§,	§§,	§§§	
	
Antenatal	corticosteroids	(n)	 -	 26	(87%)	 22	(73%)	 0.197	
Multiple	births	(n,	%)	 2	(3%)	 10	(33%)	 5	(17%)	 0.001	
Caesarean	section	(n,	%)	 10	(17%)	 16	(53%)	 9	(30%)	 0.001	
Maternal	smoking	(n,	%)	 11	(18%)	 12	(40%)	 11	(37%)	 0.05	
Maternal	fever	(n,	%)	 2	(3%)	 3	(10%)	 1	(3%)	 0.349	
Prolonged	rupture	of	membranes	(n,	%)	 3	(5%)	 10	(33%)	 6	(20%)	 0.002	
	 	 	 	 	
Inotropic	support	(n,	%))	 -	 -	 6	(20%)	 -	
Patent	ductus	arteriosus	(n,	%)	 27	(45%)	 7	(23%)	 19	(63%)	 0.008	
	 	 	 	 	
Ventilation	/	respiratory	parameters	 	 	
Surfactant	therapy	(n,	%)	 -	 -	 30	(100%)	 	
Conventional	ventilation:HFOV	(n)	 -	 -	 26:4	 	
Highest	peak	pressure	(cmH20)	 -	 -	 21.8	(3.9)	 -	
Duration	of	ventilation	(days)	 -	 -	 14.0	(17.5)	 -	
Duration	of	O2	dependency	(days	 -	 4.4	(7.9)		 57.9	(83.6)	 <0.001	
Postnatal	steroids	(n,	%)	 -	 -	 0	(%)	 	
Bronchopulmonary	dysplasia*	(n,	%)	 -	 -	 10	(33%)	 -	
	 	 	 	 	
Necrotising	enterocolitis	(n,	%)	 -	 -	 4	(13%)	 -	
ROP	threshold	(Stage	2	plus	or	above)	(n,	%)	 -	 -	 4	(13%)	 -	
IVH	(grade	3	or	4)	 -	 -	 3	(10%)	 -	











	 Term	Control		 PT	Control		 PT-RDS		 p-value	
Numbers	
Birth	 60	 30	 30	 -	
At	term	 60	 22	 19	 -	
1	month	 45	 17	 15	 -	
1	year	 33	 18	 16	 -	
Age	(weeks)	 	 	 	 	
Birth	 39.8(1.2)	 32.7(1.4)	 28.2(2.7)	 <0.001§,§§,§§§	
At	term	 "	 37.3(1.9)	 36.7(1.4)	 <0.001§§,§§§	
1	month	 5.3(1.0)	 4.6(1.8)	 3.8(1.6)	 0.002‡‡	
1	year	 53.0(2.3)	 51.9(3.5)	 49.2(4.2)	 0.001§§,§§§	
Weight	(kg)	 	 	 	 	
Birth	 3.4(0.5)	 1.8(0.4)	 1.2(0.4)	 <0.001§,§§,§§§	
At	term	 "	 2.5(0.7)	 2.3(0.4)	 <0.001§§,§§§	
1	month	 4.5(0.6)	 4.3(0.8)	 4.1(0.5)	 0.064	
1	year	 9.8(1.1)	 9.5(1.2)	 8.8(1.4)	 0.041††	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Systolic	BP	(mmHg)	 	 	 	 	
Birth	 66.9(11.7)	 65.1(10.8)	 49.3(7.8)	 <0.001§,§§	
At	term	 "	 65.8(10.1)	 49.1(6.7)	 <0.001§,§§	
1	month	 95.6(14.0)	 95.3(14.5)	 99.1(20.7)	 0.765	
1	year	 106.3(21.2)	 107.8(18.7)	 92.2(14.1)	 0.058	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Diastolic	BP	(mmHg)	 	 	 	 	
Birth	 41.3(9.9)	 37.1(7.8)	 30.8(7.5)	 <0.001†,§§	
At	term	 "	 37.2(8.3)	 29.1(6.0)	 <0.001†,§§	
1	month	 60.7(11.0)	 57.7(13.4)	 58.6(13.3)	 0.688	
1	year	 70.1(14.4)	 71.5(13.3)	 61.5(10.9)	 0.095	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Heart	rate	(bpm)	 	 	 	 	
Birth	 115(19)	 136(15)	 143(16)	 <0.001§§,§§§	
At	term	 "	 159(16)	 155(12)	 <0.001§§,§§§	
1	month	 152(17)	 160(21)	 153(14)	 0.276	
1	year	 125(15)	 131(20)	 127(17)	 0.473	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
End-diastolic	left	ventricular	chamber	lengths	(cm)	
Birth	 2.8(0.3)	 2.1(0.2)	 1.8(0.3)	 <0.001§,§§,§§§	
At	term	 "	 2.5(0.4)	 2.6(0.4)	 <0.01††,‡‡‡	
1	month	 3.1(0.2)	 3.1(0.2)	 3.0(0.2)	 0.263	
1	year	 4.0(0.2)	 3.9(0.3)	 3.9(0.2)	 0.340	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
End-diastolic	right	ventricular	chamber	lengths	(cm)	
Birth	 2.6(0.3)	 2.0(0.2)	 1.8(0.3)	 <0.001§,§§,§§§	
At	term	 "	 2.3(0.4)	 2.4(0.3)	 <0.001‡‡,‡‡‡	
1	month	 3.0(0.2)	 3.1(0.3)	 2.9(0.2)	 0.420	
1	year	 3.9(0.2)	 3.9(0.3)	 3.8(0.2)	 0.636	
ANOVA	(p	value)		 <0.001	 <0.001	 <0.001	 	








	 Term	Control		 PT	Control		 PT-RDS		
ANOVA	
p-value	
LVOT_d	(cm)	 	 	 	 	
						Birth	 0.66(0.07)	 0.53(0.06)	 0.45(0.08)	 <0.001§,§§,§§§	
						At	term	 "	 0.62(0.06)	 0.58(0.06)	 <0.001§§	
						1	month	 0.77(0.07)	 0.75(0.06)	 0.73(0.07)	 0.109	
						1	year	 0.98(0.07)	 0.96(0.07)	 0.92(0.08)	 0.097	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LVOT	VTI	(cm)	 	 	 	 	
						Birth	 12.5(2.4)	 10.2(2.3)	 8.6(2.5)	 <0.001†,§§,§§§	
						At	term	 "	 12.7(2.9)	 13.2(2.0)	 0.583	
						1	month	 13.9(2.2)	 15.0(2.0)	 14.5(1.6)	 0.206	
						1	year	 17.2(1.7)	 16.9(2.0)	 16.8(2.8)	 0.870	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Stroke	volume	(ml)	 	 	 	 	
						Birth	 4.3(1.2)	 2.3(0.8)	 1.4(0.6)	 <0.001‡,§§,§§§	
						At	term	 "	 2.5(0.7)	 2.3(0.4)	 0.014††	
						1	month	 6.5(1.5)	 6.7(1.3)	 6.0(1.0)	 0.314	
						1	year	 12.8(1.6)	 12.1(1.8)	 11.3(2.3)	 0.043††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Cardiac	output	(ml/min)	 	 	 	 	
						Birth	 489(125)	 305(114)	 194(83)	 <0.001‡,§§,§§§	
						At	term	 "	 624(204)	 541(142)	 0.002‡‡‡	
						1	month	 989(248)	 1070(247)	 909(151)	 0.151	
						1	year	 1600(290)	 1590(262)	 1420(221)	 0.081	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LV	Ds’	(mm)	 	 	 	 	
						Birth	 4.6(1.0)	 3.4(0.8)	 2.6(1.0)	 <0.001‡,§§,§§§	
						At	term	 "	 5.8(1.3)	 5.0(1.1)	 <0.001†,§§§	
						1	month	 7.5(1.2)	 7.2(0.8)	 6.6(0.9)	 0.037††	
						1	year	 9.5(1.2)	 8.7(1.1)	 8.5(1.0)	 0.007††,†††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LVbl	long	axis	shortening	(%)	
						Birth	 16.3(3.6)	 15.7(3.5)	 14.0(5.1)	 0.047††	
						At	term	 "	 22.6(3.0)	 18.8(3.1)	 <0.001‡,††,§§§	
						1	month	 23.7(3.8)	 23.0(2.6)	 21.9(2.6)	 0.200	
						1	year	 24.0(3.0)	 22.2(2.3)	 21.9(2.3)	 0.022††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	E	(m/s)	 	 	 	 	
						Birth	 0.64(0.12)	 0.52(0.11)	 0.47(0.14)	 <0.001§§,§§§	
						At	term	 "	 0.96(0.24)	 0.94(0.20)	 <0.001§§,§§§	
						1	month	 1.04(0.21)	 1.08(0.18)	 1.09(0.16)	 0.649	
						1	year	 1.18(0.15)	 1.16(0.19)	 1.11(0.09)	 0.271	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	A	(m/s)	 	 	 	 	
						Birth	 0.57(0.11)	 0.56(0.11)	 0.52(0.13)	 0.081	
						At	term	 "	 0.92(0.22)	 0.91(0.15)	 <0.001§§,§§§	
						1	month	 0.90(0.20)	 1.00(0.22)	 0.94(0.14)	 0.270	
						1	year	 0.88(0.16)	 0.92(0.18)	 0.79(0.19)	 0.106	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	E:A	 	 	 	 	
						Birth	 1.13(0.23)	 0.95(0.18)	 0.92(0.22)	 <0.001§§,§§§	
						At	term	 "	 1.03(0.13)	 1.02(0.21)	 0.054	
Kotecha	22	
	
						1	month	 1.14(0.18)	 1.06(0.18)	 1.10(0.17)	 0.293	
						1	year	 1.36(0.22)	 1.23(0.21)	 1.44(0.22)	 0.030†	



























LV	Vsbl	(cm/s)	 	 	 	 	
						Birth	 3.0(0.8)	 2.1(0.7)	 1.7(0.8)	 <0.001§§,§§§	
						At	term	 "	 3.4(0.8)	 3.1(1.0)	 0.121	
						1	month	 4.3(0.9)	 4.3(1.2)	 3.9(1.1)	 0.481	
						1	year	 4.8(1.0)	 4.7(1.0)	 4.7(0.7)	 0.861	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	Vebl	(cm/s)	 	 	 	 	
						Birth	 4.5(1.1)	 3.5(1.1)	 2.5(1.2)	 <0.001‡,§§,§§§	
						At	term	 "	 6.8(1.5)	 5.9(1.9)	 <0.001§§,§§§	
						1	month	 9.1(2.4)	 8.3(2.6)	 8.2(2.5)	 0.292	
						1	year	 11.7(2.1)	 11.0(1.9)	 10.8(1.2)	 0.190	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	Vabl	(cm/s)	 	 	 	 	
						Birth	 3.7(1.4)	 3.1(1.1)	 2.8(1.2)	 0.003‡‡	
						At	term	 "	 4.9(1.0)	 4.2(0.9)	 0.015†††	
						1	month	 5.2(1.1)	 4.8(1.2)	 4.0(1.9)	 0.178	
						1	year	 3.7(1.6)	 3.6(1.0)	 3.4(0.8)	 0.850	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	lateral	wall	mid-segment	longitudinal	peak	systolic	strain,	Ssl	(%)	
						Birth	 -22.8(3.9)	 -21.2(3.8)	 -18.9(4.9)	 <0.001§§	
						At	term	 "	 -25.5(5.1)	 -22.8(4.7)	 0.041†††	
						1	month	 -27.7(5.3)	 -27.2(3.1)	 -27.5(4.7)	 0.928	
						1	year	 -31.7(4.0)	 -31.0(3.6)	 -29.1(3.2)	 0.079	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRsl	(/s)	 	 	 	 	
						Birth	 -2.2(0.8)	 -1.9(0.5)	 -2.0(0.8)	 0.116	
						At	term	 "	 -2.4(0.7)	 -2.3(0.9)	 0.758	
						1	month	 -2.5(1.1)	 -2.9(0.6)	 -2.4(1.0)	 0.370	
						1	year	 -3.4(1.2)	 -3.1(1.0)	 -3.3(1.1)	 0.627	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRel	(/s)	 	 	 	 	
						Birth	 2.7(0.9)	 3.1(0.9)	 2.6(0.9)	 0.172	
						At	term	 "	 4.5(1.4)	 3.8(1.3)	 <0.001§§,§§§	
						1	month	 5.0(1.3)	 4.6(1.2)	 5.4(1.2)	 0.178	
						1	year	 6.0(1.5)	 5.6(1.1)	 5.1(0.7)	 0.068	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRal	(/s)	 	 	 	 	
						Birth	 2.4(1.0)	 2.5(0.8)	 2.8(0.9)	 0.188	
						At	term	 "	 3.0(0.8)	 2.9(1.1)	 0.123	
						1	month	 3.5(1.2)	 3.1(1.4)	 2.9(1.3)	 0.394	
						1	year	 2.7(1.1)	 2.3(0.7)	 2.1(0.7)	 0.135	





	 Term	Control	 PT	Control	 PT-RDS	
ANOVA	
p-value	
RV	Ds’	(mm)	 	 	 	 	
						Birth	 7.6(1.3)	 5.9(1.1)	 4.4(1.3)	 <0.001§,§§,§§§	
						At	term	 "	 8.4(1.7)	 8.4(1.2)	 0.030	
						1	month	 9.6(1.4)	 10.4(1.7)	 10.2(1.3)	 0.119	
						1	year	 14.4(1.8)	 14.6(2.0)	 13.4(2.0)	 0.113	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
RV	long	axis	shortening	(%)	 	 	 	 	
						Birth	 28.7(4.5)	 29.2(4.4)	 25.1(6.6)	 0.003‡,‡‡	
						At	term	 "	 35.6(4.3)	 35.7(6.8)	 <0.001§§,§§§	
						1	month	 31.9(4.3)	 34.1(3.6)	 34.6(3.8)	 0.037	
						1	year	 37.0(4.9)	 37.6(3.6)	 34.8(4.6)	 0.169	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
RV	Vsbl	(cm/s)	 	 	 	 	
						Birth	 4.3(0.9)	 3.7(0.8)	 2.7(0.8)	 <0.001§,§§,‡‡‡	
						At	term	 "	 4.9(1.5)	 4.7(1.1)	 0.059	
						1	month	 5.4(1.3)	 6.0(1.1)	 5.8(1.1)	 0.283	
						1	year	 7.7(1.9)	 7.9(2.0)	 7.2(1.9)	 0.525	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	Vebl	(cm/s)	 	 	 	 	
						Birth	 6.1(1.8)	 4.4(1.8)	 4.3(2.3)	 <0.001§§,§§§	
						At	term	 "	 8.9(3.8)	 7.4(3.0)	 <0.001§§§	
						1	month	 11.2(4.2)	 9.7(3.1)	 12.1(4.9)	 0.257	
						1	year	 12.9(4.0)	 11.2(3.2)	 12.6(4.4)	 0.331	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	Vabl	(cm/s)	 	 	 	 	
						Birth	 5.7(1.2)	 5.3(1.2)	 4.5(1.4	 0.002‡‡	
						At	term	 "	 7.0(2.1)	 6.1(1.8)	 0.030	
						1	month	 5.3(1.7)	 6.5(2.0)	 5.5(1.0)	 0.238	
						1	year	 6.4(2.5)	 7.0(2.4)	 6.3(1.4)	 0.627	
						ANOVA	(p-value)	 <0.001	 <0.05	 <0.001	 	
RV	free	wall	mid-segment	longitudinal	peak	systolic	strain,	Ss	(%)	
						Birth	 -27.6(5.8)	 -25.0(5.5)	 -23.2(6.7)	 0.004‡‡	
						At	term	 "	 -34.2(5.1)	 -34.9(5.6)	 <0.001§§,§§§	
						1	month	 -34.2(4.4)	 -34.2(3.7)	 -34.4(5.3)	 0.989	
						1	year	 -40.9(3.9)	 -40.3(3.2)	 -39.1(4.5)	 0.315	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRs	(/s)	 	 	 	 	
						Birth	 -2.4(0.7)	 -2.3(0.7)	 -2.2(0.8)	 0.490	
						At	term	 "	 -3.4(0.8)	 -3.5(0.6)	 <0.001§§,§§§	
						1	month	 -4.1(0.9)	 -3.9(1.0)	 -3.5(0.9)	 0.095	
						1	year	 -4.4(1.0)	 -4.5(1.0)	 -3.7(0.9)	 0.032†	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRe	(/s)	 	 	 	 	
						Birth	 2.7(0.9)	 2.4(0.8)	 2.8(1.2)	 0.182	
						At	term	 "	 5.0(1.6)	 3.9(1.7)	 <0.001†,‡‡,§§§	
						1	month	 5.8(1.9)	 5.0(1.6)	 5.5(1.9)	 0.359	
						1	year	 6.2(1.2)	 6.1(1.5)	 5.4(1.1)	 0.113	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRa	(/s)	 	 	 	 	
						Birth	 2.9(0.9)	 3.1(0.8)	 3.0(1.3)	 0.556	
Kotecha	25	
	
						At	term	 "	 5.4(1.1)	 4.2(0.9)	 <0.001‡,§§,§§§	
						1	month	 4.6(1.7)	 3.5(1.0)	 3.6(1.6)	 0.062	
						1	year	 3.9(1.3)	 3.4(1.4)	 2.9(0.9)	 0.077	

















	 Term	Control	 PT	Control	 PT-RDS	
ANOVA	
p-value	
PAAT	(ms)	 	 	 	 	
Birth	 70.3(11.9)	 64.2(15.1)	 52.6(11.3)	 <0.001‡,§§	
At	term	 "	 57.3(10.2)	 49.5(11.2)	 <0.001§§,§§§	
1	month	 							61.1(8.9)	 							54.8(6.5)	 							54.2(7.6)	 0.005††,†††	
1	year	 79.5(10.9)	 83.1(10.4)	 84.7(15.8)	 0.316	
ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RVET	(ms)	 	 	 	 	
Birth	 224.6(20.7)	 208.2(19.7)	 198.1(26.3)	 <0.001§§,‡‡‡	
At	term	 "	 197.4(15.9)	 202.0(15.8)	 <0.001§§,§§§	
1	month	 199.2(16.0)	 193.8(14.9)	 197.4(13.5)	 0.479	
1	year	 236.3(20.2)	 234.6(19.0)	 238.3(24.5)	 0.874	
ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
PAAT:RVET	ratio	 	 	 	 	
Birth	 0.31(0.04)	 0.31(0.06)	 0.27(0.04)	 <0.001‡,§§	
At	term	 "	 0.29(0.06)	 0.25(0.06)	 <0.001†,§§	
1	month	 0.31(0.05)	 0.28(0.03)	 0.27(0.03)	 0.015††	
1	year	 0.34(0.05)	 0.35(0.03)	 0.35(0.05)	 0.287	












Figure	 1:	 Measurement	 of	 LV	 chamber	 length,	 LV	 annular	 displacement	 and	 derivation	 of	 LV	 long	 axis	
shortening.	
	
On	this	static	image,	the	endocardial	border	at	the	apex	is	not	well	defined	but	during	analysis	its	position	
was	determined	by	reviewing	the	cine	loop.	
	
	
Figure	2:	LV	strain	measurement	in	the	middle	segment	of	the	LV	free	wall.	
